Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date17 Mar 2020 |
100 Clinical Results associated with Guangxi Wuhe Boao Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Guangxi Wuhe Boao Pharmaceutical Co., Ltd.
100 Deals associated with Guangxi Wuhe Boao Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Guangxi Wuhe Boao Pharmaceutical Co., Ltd.